ABOS Acumen Pharmaceuticals
- 3.490
- +0.010+0.29%
- 3.480
- -0.010-0.29%
Acumen Pharmaceuticals News
Acumen Pharmaceuticals | EFFECT: Others
Acumen Pharmaceuticals | ARS: Annual Report to Security Holders
Acumen Pharmaceuticals | DEFA14A: Others
Acumen Pharmaceuticals | DEF 14A: Definitive information statements
Acumen Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers
Acumen Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Acumen Pharmaceuticals | 10-K: Annual report
Acumen Pharmaceuticals | 8-K: Current report
Acumen Pharmaceuticals | 8-K: Current report
Acumen Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(0%),Deep Track Biotechnology Master Fund, Ltd.(0%), etc.
Acumen Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Franklin Resources, Inc.(5.8%),Franklin Advisers, Inc.(5.7%)
Acumen Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Doherty James J.
Acumen Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Doherty James J.
Acumen Pharmaceuticals | 8-K: Current report
Acumen Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-James B. Murray, Jr.(4.6%)
Acumen Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer OConnell Daniel Joseph
Acumen Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Meisner Derek M
Acumen Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Zuga Matt
Acumen Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Siemers Eric
Acumen Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Barton Russell
Analysis
Price Target
No Data
